Comparative Pharmacology
Head-to-head clinical analysis: NEPHROSCAN versus TECHNEGAS KIT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NEPHROSCAN versus TECHNEGAS KIT.
NEPHROSCAN vs TECHNEGAS KIT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium trisodium pentetate (NEPHROSCAN) chelates gadolinium ions by forming a stable complex with the metal, thereby reducing the toxicity and enhancing elimination of gadolinium from the body. It acts as a decorporation agent for gadolinium.
Technetium Tc-99m generator that produces pertechnetate ion, which is taken up by thyroid, salivary glands, stomach, and choroid plexus; also used for radiolabeling of other compounds.
1 to 5 mCi (37 to 185 MBq) as a single intravenous injection for renal imaging.
Inhalation: 740-1110 MBq (20-30 mCi) of Technetium-99m DTPA aerosol, administered via nebulizer over 3-5 minutes.
None Documented
None Documented
Terminal elimination half-life: 1.6 hours in normal renal function; prolonged to >20 hours in severe renal impairment (CrCl <30 mL/min).
Physical half-life of 99mTc: 6.02 hours; effective half-life after inhalation: approximately 6.02 hours (clearance limited by physical decay, as the agent is inert)
Renal: 95% as unchanged drug via glomerular filtration; no biliary/fecal excretion.
Renal: 100% as unchanged pertechnetate (99mTcO4-); biliary/fecal: negligible
Category C
Category C
Diagnostic Radiopharmaceutical
Diagnostic Radiopharmaceutical